Insulin insurance coverage has improved dramatically thanks to the Inflation Reduction Act, which capped Medicare Part D insulin copays at $35/month. Many states and commercial insurers have followed suit with their own insulin cost caps. Despite these improvements, some patients still face affordability challenges depending on their plan type and insulin product.
Key Facts
Check Your Specific Plan's Formulary
Coverage varies by plan. Use our formulary checker tool to look up your exact copay and restrictions.
Open Formulary CheckerSources and standards behind this page
Drug coverage in the United States is governed by published rules rather than by any one insurer's summary, and the sources below are the primary ones. They are linked so a reader can check a claim without taking this page's word for it.
- FDA Orange Book publishes the therapeutic-equivalence ratings that decide whether a generic may be substituted for a brand-name drug.
- FDA generic drug facts sets out what "generic equivalent" means and what a manufacturer must prove.
- CMS prescription drug coverage defines the rules a Medicare drug plan formulary must follow and how it may change mid-year.
- Medicare.gov drug coverage (Part D) states what a Part D plan is required to offer a member.
- CMS prescription drug appeals documents the coverage-determination and exception process when a drug is denied.
This page describes how coverage and formularies work. It is not medical advice, and a reader's own plan documents and prescriber decide what applies to them.
Frequently Asked Questions
Insulin is not universally free, but costs are significantly reduced. Medicare Part D caps insulin at $35/month. Many commercial plans offer $0 to $35 copays. Some states have passed laws capping insulin copays. Check your specific plan, as coverage varies. Manufacturer programs like Lilly's $35 cap apply regardless of insurance status.
Preferred (formulary) insulins on your plan's lowest tier will be cheapest. Biosimilar insulins like Semglee and interchangeable biosimilars are often on preferred tiers. Check your formulary to see which insulin brands and types are preferred. Switching to a preferred insulin can save hundreds per year.
Most insurance plans cover insulin pumps and continuous glucose monitors (CGMs) for type 1 diabetes and insulin-dependent type 2 diabetes. Coverage may fall under durable medical equipment (DME) with separate deductibles and copays. Prior authorization and documentation of medical necessity are typically required.
Related Resources
- Medicare Part D Formulary 2026
- UnitedHealthcare Formulary 2026
- Medicaid Drug Coverage 2026
- Metformin cash price comparison on RxGrab
- Ozempic cash price comparison on RxGrab
- Jardiance cash price comparison on RxGrab
- Mounjaro cash price comparison on RxGrab
- Farxiga cash price comparison on RxGrab
- Patient assistance programs
- Ozempic patient assistance program
- Jardiance patient assistance program
- Drug interaction checker tool
- Patient assistance program finder
Get Formulary and Coverage Updates
Subscribe to receive alerts on formulary changes, new drug approvals, and insurance coverage updates.